Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Source updated2026-09-21Last update listed in the registry record
Version history
Changes to this trial
Last 12 months
Pro unlocks the full available history and CSV export. View Pro features
· 4 fields changed
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before
Measure: Number of adverse events in those treated with sevasemten or placebo
Measure: Severity of adverse events in those treated with sevasemten or placebo
Measure: Change from Baseline in serum Creatine Kinase
Measure: Change from Baseline in the North Star Ambulatory Assessment scale
+ After
Measure: Number of treatment emergent adverse events in those treated with sevasemten or placebo
Measure: Severity of treatment emergent adverse events in those treated with sevasemten or placebo
Measure: Change from Baseline in serum Creatine Kinase
Measure: Change from Baseline in total North Star Ambulatory Assessment score
Trial